Related Experiment Video
Updated: Jun 20, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
Chen-Ju Lin1, Abba Malina, Jerry Pelletier
1Department of Biochemistry and McGill Cancer Center, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada.
The Myc and eukaryotic initiation factor 4F (4F) complex regulate cell growth and cancer. Myc increases 4F activity, driving cell transformation, suggesting therapeutic inhibition for cancer treatment.
Area of Science:
- Molecular biology
- Cellular biology
- Oncology
Background:
- The Myc/Max/Mad transcription factors and eukaryotic initiation factor 4F (4F) complex are crucial for cell growth, proliferation, differentiation, and oncogenesis.
- Myc's role in cell growth and proliferation is increasingly linked to enhanced eIF4F activity.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying Myc-driven cell transformation.
- To explore the potential of targeting Myc and/or eIF4F for cancer therapy.
Main Methods:
- This study integrates findings from molecular and cellular biology research.
- The research focuses on the regulatory relationship between Myc and eIF4F activity.
Main Results:
- A feedforward relationship exists where Myc enhances eIF4F activity, contributing to cell transformation.
- This interplay provides a potential molecular basis for Myc's oncogenic functions.
Conclusions:
- Targeting the Myc/eIF4F pathway presents a promising therapeutic strategy for various human cancers.
- Inhibiting eIF4F and/or Myc could offer novel treatments for oncological conditions.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
Cells Coordinate Growth and Proliferation
Cells Coordinate Growth and Proliferation

